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ABSTRACT 
This report evaluates the pros and cons of using carbadox, a feed additive tor pigs that has two 
claims: (1} growth promotion, (2} prevention against swine dysentery. 
Carbadox is effective in the prevention of swine dysentery. As a growth promoter, however, its effecti-
veness is marginal (if farming conditions are optimal} . 
Carbadox is considered to be a genotoxic carcinogen. In addition it exerts adrenal taxicity in target 
animals. The compound has significant dusting properties. 
Applying good agricultural and veterinary practice, residue formation of carbadox (and its metabolites) 
in edible products is negligible. Hence there is no risk tor the consumer. 
The applications of carbadox have hardly any alternative. 
The benefits of carbadox need to be weighed carefully against its disadvantage, i.e. the principle of 
avoiding the use of carcinogenic compounds. Unfortunately, actual research data regarding the 
exposure of workers in the feeding industry and farms working with carbadox, that are needed tor 




Dit rapport evalueert de voor- en nadelen van het gebruik van carbadox, een veevoederadditief voor 
varkens met twee effecten: (1) groeibevordering, (2) preventie tegen varkensdysenterie. 
Carbadox geeft goede preventie tegen varkensdysenterie. Onder optimale bedrijfsomstandigheden 
is de groeibevorderende werking echter marginaal. 
Carbadox wordt als genotoxisch carcinogeen beschouwd. Daarnaast is het toxisch voor de bijnier van 
het doeldier. De stof heeft de eigenschap gemakkelijk te verstuiven. 
Onder de condities van goede agrarische en veterinaire praktijk zijn de residuen van carbadox (en 
metabolieten) in eetbare producten verwaarloosbaar, zodat de consument geen risico loopt. 
Met betrekking tot de toepassingen van carbadox zijn er nauwelijks alternatieven. 
Er dient een afweging gemaakt te worden tussen enerzijds de voordelen van het gebruik van 
carbadox, en anderzijds het principe dat gebruik van carcinogene stoffen vermeden dient te worden. 
Helaas ontbreken de voor deze afweging noodzakelijke actuele gegevens met betrekking tot de 
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Carbadox (methyl-3-(2-quinoxalinylmethylene)-carbazate-N\N4-dioxide, Mecadox®) is a feed additive 
used in rearing pigs. lt is primarily used as a growth-promoting agent, or as the case may be, to 
imprave feed-conversion. Secondarily it is used as a prevenlive agent against anaerobic intestinal 
infections, in particular Serpulina hyodysenteriae (previously known as Treponema hyodysentariae) -
swine dysentery or dysentery Doyle. Carbadox was introduced in 1971 (Gropp et al, 1971, 1972) and 
has been accepted as a means to imprave growth without a working mechanism being claimed 
('group K'). In the EU the substance is allowed tor administration to young pigs in doses of 20-50 ppm 
(pr.trts per million, mg per kg) inthefeed trom a tew weeks befare weaning until the age of 14 weeks. 
Then a withdrawal period of 4 weeks needs to be adhered to befare the animal can be slaughtered 
(Schumer, 1990). 
2 EFFECTIVENESS 
- growth promotion 
In the first period following the introduetion of carbadox, claims were made of improvements in feed-
conversion and thus in growth-promotion of up to 25 %. In later years, this percentage dropped to a 
feed-conversion impravement of 5 % at most. In all probability this phenomenon (in the first instanee 
having a high growth-promoting effect, and then later a considerably reduced effect) has to be 
attributed to improved hygienic farming conditions and to the adoption of a feeding-regime better 
suited to the needs of the animals. In the early stages already, it was suggested that carbadox could 
have an 'insulin-type' of effect. Besides this, it has also been shown that there is a link between the 
growth-promoting effect and lysine concentrations in the feed: with a low lysine level in the feed, the 
growth-promoting effect of carbadox was optima!. In other words, carbadox has a lysine-saving effect 
(Gropp & Wagner, 1990: Gropp et al, 1990}. Under optima! conditions it appears that the growth-
promoting effect of carbadox is otherwise nil. (Nabuurs & van der Molen, 1989). 
- prevention of swine dysentery 
Using the dosages allowed, carbadox offers good prevention against anaerobic intestinal infections, 
in particular Serpulina hyodysenteriae (previously known as Treponema hyodysentariae), also known 
as swine dysentery or dysentery Doyle. Carbadox is, however, nat effective against an infection that 
is already present: the proteetion is exclusively preventive. In spite of being widely used during the 
past 25 years, carbadox has so far shown no resistance to the above mentioned anaerobic diseases. 
Contrary to this, resistance has been noted to aerobic pathogens such as Escherichia co/i (Kital et 
al, 1979; Ohmae et al, 1981 ; Droumev, 1983; Baumgartner et al, 1985; Holá & Sevcik, 1990}. 
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- alternatives 
As far as is known, the feed-additive olaquindox (chemically closely related to carbadox) has similar 
growth-promoting properties, although to a less effective degree. As a preventative against swine 
dysentery, olaquindox is here again clearly less effective: the MIC (minimum inhibitory concentration) 
tor Serpulina hyodysenteriae is ten times higher than the MIC of carbadox tor this pathogen (Vijfhuizen 
et al, 1988}. 
Tylosine has been accepted as a feed additive as well as an animal medication tor the prevention and 
cure of swine dysentery. Tylosine is, therefore, both a prophylactic as well as a therapeutic remedy 
(carbadox is exclusively prophylactically effective) . 
Unfortunately, however, resistance to tylosine has been noted on a large scale: already in 1988 all 35 
field isolates of Serpulina hyodysenteriae in The Netherlands displayed an insensitivity to tylosine 
(Vijfhuizen et al, 1988}. 
In Sweden, carbadox (and olaquindox) are no langer allowed as feed-additives. This has led, on the 
one hand, to its de facto but not monitorable use through prescription by veterinary surgeons, and 
on the other hand, tor the benefit of growth-promotion as well as the prevention of swlne dysentery, 
thP. application of (very) large amounts of zinc oxide - up to thousands of ppms in the feed (Best, 
1996; Björnerot et al, 1996}. The growth-promoting capabilities of zinc preparations are highly 
questionable; furthermore, hardly any literature can be found about the effectiveness of zinc as a 
preventalive against swine dysentery. Zinc is an essential micro-nutrient, the absorption of which is 
physiologically regulated. Administration of larger than homeostatically applicable amounts will thus 
not result in greater absorption, but only lead to direct and almast always quantitative excretions. 
Regardless of the possible beneficia! effects to the animal, the application of zinc might potentially 
create an environmental problem that could have serious repercussions more or less like the wide-
ranging consequences of the earlier high use of capper in the pig sector. 
Besides, the use of a preventative agent against swine dysentery is superfluous when pig-farms 
operate under SPF conditions (specific pathogen tree), as is presently the case in Denmark. 
3 METABOLISM 
Studies on the metabolism of carbadox were done in rats, monkeys, and pigs with 14C-carbadox, 
labelled in the phenyl ring or in the carbonyl group of the side chain. The metabolism of carbadox is 
characterised by a quick reduction of the N-oxide groups and the cleavage of the methylcarbazate 
side chain. The primary metabolite in the urine was quinoxaline-2-carboxylic acid, which was also 
excreted in conjugated form. In the tissues, up to 24 hours after the last administration, residues of 
carbadox,desoxycarbadox, quinoxaline-1,4-di-N -oxide-2-carboxaldehyde,andquinoxaline-2-carboxylic 
acid could be observed. At the same time traces of hydrazine were found, but these were taken as 




The oral LD501 inthemale mouse is 2810 mg per kg of body weight, and > 2810 mg per kg of body 
weight in the female mouse. Following intraperitonaal administration, the LD50 in the mouse is 1050 
mg per kg of body weight. In the rat the oral LD50 is 850 mg per kg of body weight. Based on these 
data carbadox can be classified as being 'moderately taxie' (SCAN, 1980, 1984, 1986; JEFCA, 1990a, 
1990b, 1991). 
The administration of carbadox for a period of 5 weeks to 5-week old pigs in dosages of 0 to 200 ppm 
in the leed leads to damage to the zona glomerulosa2 of the adrenals in the dosage groups > 50 
ppm, that even after 11 weeks saw no recovery. This went hand in hand with a significant decline of 
the aldosterone level3 in the blood (van der Molen et al, 1988). In a similar experiment, it was noted 
that as a secondary effect, apart trom the decrease of the blood aidasterons level, also the renin-
( angiotensin4 system was affected: blood levels were significantly raised in all dosage groups (van der 
Molen et al, 1989). 
The decline of the aidasterons level in blood as a consequence of the administration of carbadox was 
confirmed in in vitro experiments (Baars et al, 1988). In continued research, it could be established 
that nat only the blood aidasterons level decreases but also the levels of glucocorticosteroids, 
corticosterone, and cortisol, while at the same time the secrelion of progesterans and analogues 
increases (Jager et al, 1994; Jager et al, 1996). Thus, it can be stated that a substantial disturbance 
of the steroid balance occurs, which has the consequence that the animal no langer reacts to salt 
imbalances and stress. Although this could be favourable tor leed-conversion under certain circum-
stances, tor the most part it has of course serious physiological consequences in generaL 
Regardless of the experimental indications of the carcinogenicity of carbadox (see further on) there 
are recent indications that disturbances of the steroid balance, such as caused by carbadox 
1 The LD50 is the single dose after which 50 % of the experimental animals die within 24 hours. To illustrate 
the 'moderate toxlcity' of carbadox: lts taxicity is between that of lead (with a LD50 of 120 mg/kg) and that 
of camman salt (with a LD50 of 4000 mg/kg). 
2 The zona glomerulosa of the adrenal is defined as the cell layer between cortex and medulla. These cells 
produce aldosterone. 
3 Aidasterons is ons of the mineralocorticoid steroid hormones, responsibis tor the reguiatien of water and 
salt homeaslasis of the organism. 
4 Renin Is a glycoprotein produced by the kidneys. lt stimulates the release of angiotensln, a glycoprotein 
hormone produced by the liver. Angiotensin acts as a vasocontrictor and increases blood pressure. lt is 
also involved in the reguiatien of the blood aldosterone level. 
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(decrease of circulating corticosteroids and an increase of circulating progestagens), can by itself 
increase tumour incidence (Zumoff et al, 1981; Labrie et al, 1987; Gornes et al, 1988; Najid & 
Habrioux, 1990). 
In addition recent research has made clear that not only olaquindox has photo-toxic properties (which 
was already known earlier), but also carbadox exhibits a certain degree of photo-toxicity in exposed 
humans, or, as the case may be, photo-allergenicity (Dawson & Scott, 1972; de Vries et al, 1990). 
Supplementary to this, it can also be mentioned that data gathered trom a 3-generation study of rats 
and a development study of rabbits treated with quinoxaline-2 carboxylic acid do not lead to positive 
findings that could indicate teratogenicity and embryotaxicity of this end-metabolite (JEFCA, 1990a, 
1990b, 1991). 
( 5 CARCINOGENICITY 
- carbadox 
In several chronic feed tests with rats, a dose-dependent increase of benign and malign tumours was 
observed at dosages of ~ 1 mg carbadox per kg of body weight per day. Dosages of over 25 mg per 
kg of body weight were extremely toxic, so that the experiments could not be continued further. In 14 
out of 15 genotoxicity studies in various mammals and non-mammals, positive results were reported. 
On the basis of these findings it was concluded that carbadox is obviously genotoxic and carcinogenic 
(SCAN, 1980, 1984, 1986; JEFCA, 1990a, 1990b, 1991). 
- desoxycarbadox 
The chronic administration of desoxycarbadox in a study with rats also resulted in an increase of 
tumour incidence. In all dosage groups (5 to 25 mg per kg of body weight per day) the incidence 
increased, mostly in the liver, but also in the skin and mammary glands (SCAN, 1980, 1984, 1985; 
JEFCA, 1990a, 1990b, 1991). Although desoxycarbadox scored negative in most mutagenicity tests, 
positive findings were reported in the cell transformation test and the Ames test with liver mierosomes 
trom rats pre-treated with PCBs. On the basis of these results, it was concluded that desoxycarbadox 
has probably a greater turncrigenie potential than the parent compound, so that desoxycarbadox most 
likely contributes significantly to the turncrigenie activity of carbadox in rats. According to the JEFCA 
(1990a, 1990b, 1991 ), the contri bution of desoxycarbadox to carcinogenicity is nevertheless limited 
because desoxycarbadox is a short-living intermediary metabolite that quickly converts into 




The available information concerning methylcarbazate, a side-chain metabolite of carbadox, was 
limited. With this in mind it was concluded that neither the chronic studies in rats, nor the genrally 
used mutagenicity tests had led to positive findings. In other words, these studies do not indicate any 
carcinogenic and/or mutagenic potential of methylcarbazate (SCAN, 1980, 1984, 1986; JEFCA 1990a, 
1990b, 1991) 
-hydrazine 
The structure of carbadox suggests that hydrazine is possibly a further metabolite of methylcarbazate. 
On the basis of the known pharmacokinetic properties of hydrazine and its chemica! reactivity, it was 
hypothesized that this metabolite would quickly get eliminated. Consequently, it was concluded that, 
in spite of its known carcinogenicity and mutagenicity, the contribution of hydrazine to the 
carcinogenicity (and taxicity in general) of carbadox would at best be marginal (JEFCA, 1990a, 1990b, 
1991). 
- quinoxa/ine-2-carboxy/ic acid 
With respect to quinoxaline-2-carboxylic acid, none of the chronic studies indicated any suspicion of 
taxie, carcinogenic or mutagenic properties of this metabolite (SCAN, 1980, 1984, 1986; JEFCA, 
1990a, 1990b, 1991). 
- conc/usions regarding carcinogenicity 
The above data led bath the SCAN (1980, 1984, 1986) as wellas the JEFCA (1990a, 1990b, 1991) 
to the conclusion that the risk of the use of carbadox on the basis of the carcinogenicity of the parent 
compound and its primary metabolite desoxycarbadox was so small that its use (under certain condi-
tions) could be allowed. 
Since then, however, the apinion concerning the use of carcinogenic chemieals and suspeeled 
carcinogenic chemieals has evolved. In 1989 the RIVM (the Dutch National lnstitute of Public Health 
and the Environment) came to the conclusion that carbadox must be considered to be carcinogenic 
and genotoxic. In 1991, the Arbeidsinspectie (the Dutch Labour lnspectorate) put carbadox as a 
carcinogenic compound on the list of materials that must be registered. Likewise, on the basis of 
recommendations of the Gezondheidsraad (1979, 1988) (National Health Council of The Netherlands) 
and general EU-rules, one is generally of the apinion that the use of genataxie carcinogenic materials 
should be avoided wherever possible or just should not be allowed. 
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6 RESIDUES 
Administration of 55 mg 14C-Iabeled carbadox per kg of feed tor a period of 5 days to pigs with a body 
weight of about 30 kg resulted in a concentration of total carbadox residues in muscle tissues of 5 
pg per kg 30 days after the terminalion of this feeding-regime. After 45 days the concentration was 
decreased to 3 pg per kg, and after 70 days the level was 2 pg per kg. In liver, the concentrations 
were 74, 20 and 13, and in kidney 15, 5 and 4 pg per kg, respectively. In fat tissues the concentrations 
were 2 pg per kg after 30 days, after 45 days 1, and after 70 days < 1 pg per kg. Other residue 
studies have lead to similar results. In the liver of pigs, very small amounts of unknown metabolites 
were perceptible, even after 7 or more days after the administration had been terminated. Through 
alkali hydralysis of the liver these residues could be partly released and converted into quinoxaline-2-
carboxylic acid (JEFCA, 1990a, 1990b, 1991). 
Residues of quinoxaline-2-carboxylic acid were studied in pigs with a body weight of about 12 kg that 
had been fed over a period of47 days with feed containing 50 ppmct~rbadox. lmmediately after 
terminalion of this feeding-regime, the concentrations of quinoxaline-2-carboxylic acid in liver, kidney 
and muscle tissue we re 345, 211 and 30 pg per kg, respectively. After 7 days the concentrations were 
169, < 30, and < 30 pg per kg, respectively. In liver there still remained 83 Jlg per kg after 14 days, 
and 48 pg per kg aft er 21 days (JEFCA, 1990a, 1990b, 1991). 
In the studies mentioned above, carbadox and desoxycarbadox were only measurable during the first 
72 hours after terminalion of the administration of carbadox. lt should be stressed, however, that 
befare 1990 the detection levels were about 5 ppb (parts per billion, Jlg per kg) in plasma, urine, 
tissues and organs. lt was, therefore, assumed that after 28 days the concentrations in edible parts 
would be negligible. Although two of the three residues of carbadox in edible parts of pigs are 
supposed to be carcinogenic (carbadox and desoxycarbadox), it was also concluded that applying 
good agricultural practice, carbadox could be used in dosages of up to 50 ppm in the feed, with the 
application of a withdrawal period of 28 days (JEFCA, 1990a, 1990b, 1991 ). 
lt was noted that the - otherwise non-carcinogenic - (end)metabolite quinoxaline-2-carboxylic acid can 
serve as a marker: this metabolite can be measured for at least 28 days in tissues and organs 
(JEFCA, 1990a, 1990b, 1991), although the deleetion limit in the 1980s was 30 Jlg per kg, which is not 
exceptionally sensitive. 
Research with more sensitive analysis methods has on the one hand confirmed the concentrations 
noted during and after the administration of carbadox to pigs, but on the other hand it has now 
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become clear that the biologica! half-life of the metabolites desoxycarbadox and quinoxaline-2-
carboxylic acid in liver and kidneys is higher than was first noted. The research in question comprised 
75, 3-week old pigs, that were administered 50 ppm carbadox in the feed tor a period of 94 days. Atter 
cessation of the adminstration the animals we re slaughtered at regular intervals. Al ready one day aft er 
terminalion of the administration no residues of the parent compound could be seen up to a level of 
2 Jlg per kg. Desoxycarbadox dropped to 1 Jlg per kg in the liver atter 14 days, in the kidneys atter 
7 days, and in the muscle tissue atter 3 days. Three days atter termination of the administration the 
level of quinoxaline-2-carboxylic acid in muscle dropped to 2 Jlg per kg; theMALof 30 Jlg per kg in 
liver and kidneys was, however, only reached atter 4 to 5 weeks (Baars et al, 1990). 
In a recent experiment test mature pigs were given 50 ppm carbadox in the feed tor a period of 7 
days. Eight hours atter terminating this regimen, no residues of parent compound and metabolites 
were demonstrable, measured up toa level of 1 Jlg per kg (Keukens & Tomassen, 1995). 
Very recently a similar study was carried out to research possible residue formation as a result of 
carry-over of feeds. A number of pigs received feed with a carbadox concentration varying trom 0.5 
to 5.4 ppm. The animals were subsequently slaughtered after withdrawal periods of 0, 3 and 12 hours. 
In the group given 5.4 ppm carbadox in the feed, the carbadox-residue in meat after a 3 hour 
withdrawal period was 1 Jlg per kg, atter a 12 hour withdrawal period the concentration had dropped 
to < 0.5 Jlg per kg. In the livers and kidneys of these animals, no carbadox above the level of 0.5 Jlg 
per kg was found. After a 3 hour withdrawal period 3 Jlg per kg desoxycarbadox was noted in the 
meat, while the desoxycarbadox-concentrations in livers and kidneys were 2 and 25 Jlg per kg, 
respectively. Aftera 12 hour withdrawal period the concent ration of desoxycarbadox in meat droppad 
to < 1, in the livers to 1, and in the kidneys likewise to 1 Jlg per kg. In the lower dosage groups no 
carbadox (to the level of 0.5 Jlg per kg) and desoxycarbadox (to the level of 1 Jlg per kg) was seen 
(Keukens, 1997). 
Although the risk of residues of carbadox and/or desoxycarbadox in meat, assuming normal use of 
carbadox and observance of the prescribed withdrawal period, is thus virtually nil, this is less certain 
tor liver and kidney. 
5 The preparatien of feeds with additives can resull in contamination of the feed that is prepared aftar an 
aarlier feed preparation. This phenomenon is called 'carry-over' and occurs particularly in using high 
desages of additives and if the mixing and compressing devices and !heir raspeelive pipes have nol 
been cleaned properly. This contamination can also occur if the silo and/or the feeding troughs are nol 
completely empty befare they are tilled with new and 'clean' leed. 
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7 DUSTING PROPERTIES 
During the application of carbadox-containing feeds as well as during the production process of 
carbadox-containing concentrates, premixes and feeds, there is a certain risk of exposure tor humans. 
Such exposure could take place through direct skin contact, through inhalation of the dust matter 
generated during the production and/or feeding process, through skin contact with the excretory 
products of the animals treated, and through residues in animal products. With respect to the second 
mentioned possibility, within the EU the requirement has been set that samples of concentrales in the 
analysis according to the Stauber-Heubach procedure (Stauber & Beutel, 1984) may nat generata 
more than 0.1 pg carbadox in the dust. 
In the beginning of the 1980s, studies were done in workers involved in the preparation of a 50 ppm 
carbadox-containing feed trom a 1 o % pre mix, and then administering this feed to pigs. Emphatically 
na measures were taken to prevent dust-formation during the process. The actual exposure of 
humans as well as pigs was measured with filters tor a period of 15 days. On the average the 24-hour 
inhalatory exposure appeared to be 50 pg carbadox per kg of body weight. Unfortunately the report 
does nat make clear whether the results regard an exposure during 24 hours ar a 24-hours average 
on the basis of (tor example) an 8-hour working day. 
Experimental research has further shown that in a number of randomly taken samples, the 
requirements concerning dusting potential are aften nat fulfilled. In 25 samples in which the 
concentration of carbadox varied trom 0.5 % to 10 % it appeared that the amount of dust released, 
determined according to the prescribed method, diverged trom 0.34 to 14374 pg, with an overall 
average of 2818 pg and a median of 1610 pg (Aerts & Roozendaal, 1985). At the same time 
preliminary results showed that pretraatment of the concentrata to imprave the dusting properties has 
na effect on the dusting potential of the premixes pre pa red trom this concentrata (Aerts & Roozendaal, 
1985). Even if it is accepted that, thanks to more hygienic farming measures, the risk of exposure 
during the production process has been reduced, then there still remains the risk of exposure when 
the dust-filters used in the production process are changed. As far as is known na research regarding 
this problem has been undertaken. 
In order to allow reliable conclusions with respect to the risks of dusting tor workers in animal feed 
plants and tor people working with carbadox (whether or not added to feeds) renewed and more in-
depth research regarding the dusting properties of carbadox is strongly recommended. 
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Starting trom the requirements stipulated by the EU with respect to the maximum allowable 
concentration of carbadox in dust, as determined with the Stauber-Heubach method, an estimate can 
be made of the theoretica! exposure. The Stauber-Heubach methad (Stauber & Beutel, 1984) 
measures the amount of carbadox generaled in dust-form trom a (premix) sample of 50 g. This sample 
is placed in a standardized dust-generating drum equipped with a filter box, and rotated tor 5 minutes 
while 4 I air per minute are drawn through the drum and filter. The dust collected in this way therefore 
originates trom 20 I air, and should according to the EU-regulations nat contain more than 0.1 pg 
carbadox, equalling 5 pg per m3• Assuming a working period of 8 hours and a breathing volume of 
7 litres per minute (resting state), an average adult person will be inhalatory exposed to 7 x 60 x 8 x 
0.005 = 16.8 pg carbadox per working day, or 0.28 pg per kg of body weight per 8-hour working day. 
On a yearly basis (200 working days) this leads to a total inhalatory intake of 3.36 mg. 
8 CONCLUSIONS 
1. Although carbadox has certain growth-promoting properties tor pigs (and possibly also for other 
farm animals), its beneficia! effect is marginal (if nat al all absent) if hygienic farming conditions 
are fully optimal, and optimal feeds and optimal feeding-regimes are used. 
2. Carbadox is a good prevenlive (nat curative) agent applicable in the prevention of infections by 
Serpu/ina hyodysenteriae (previously known as Treponema hyodysenteriae), the anaerobic micro-
organism that causes swine dysentery. 
3. Carbadox and its metabolite desoxycarbadox are considered to be genataxie carcinogenic 
substances. In addition phototoxicity and photo-allergenicity have been observed. 
4. The residues of carbadox and desoxycarbadox in edible porcine produels are, with consideration 
to the rules, negligible in meat after 4 weeks, and in livers and kidneys after 6 weeks. Hence under 
conditions of Good AgriculturaiNeterinary Practica the risk of exposure to carcinogenic residues 
of carbadox for the consumer of park products is negligible. 
5. The dusting properties of carbadox in concentrates, premixes and prepared feeds may led to 
exposure of people working in feed plants or working with carbadox (whether or nat preparing 
feeds themselves) on farms. Workers in the animal feed sector where carbadox is handled thus 
are at risk of exposure to this compound. 
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6. Alternatives tor carbadox are (1} olaquindox (indications: growth-promotion and prevention against 
Serpulina hyodysenteriae infections), and (2} tylosine (indications: prevention against and therapy 
in Serpu/ina hyodysenteriae infections). 
Olaquindox belengs to the same chemica! family as carbadox: olaquindox is also suspected to 
be carcinogenic, above all the dusting properties are similar to these of carbadox. As a preventive 
agent against the above-mentioned infections it is clearly less effective than carbadox, besides 
this it is also phototoxic. 
Tylosine is not only effective as a prevenlive but also as a curative drug, but has already 
generaled resistance. 
Oparating pig-farms under SPF-conditions make the use of prevenlive agents against swine 
dysentery supertluous. 
7. The pres and eens of carbadox, i.e. its benefits as a prevention against swine dysentery vs. the 
general principal that the use of carcinogenic compounds should be avoided, needs to be 
weighed carefully against each ether. 
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The only risk groups are the workers in the feed industry and the workers in agricultural practice 
involved with carbadox and/or carbadox-containing feeds. 
However, to allow a reliable estimate of these risks, up-ta-date research data about the actual 
exposure of these people in their werking environment are needed. At present such data are 
lacking. 
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